I already told you last time it was a totally different company over 5 years ago. Do you know how much time it takes for a product to reach commercialisation??? IMU has a lot more fund and resource now so they can speed their clinical trials compared to when they only had HER-Vaxx in their pipeline. Why do you think company usually get T/O by BP when their IP are end of Ph2 clinical trial? BP have the fund and resource to take the IP to end of Ph3 and then FDA approval and commercialisation.
I already told you last time it was a totally different company...
-
- There are more pages in this discussion • 847 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17059 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 100000 | 1 |
View Market Depth
| Last trade - 09.52am 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable